Literature DB >> 27316662

Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease.

N Decorte1, M Gruet2, B Camara3, S Quetant3, L Mely4, J M Vallier5, S Verges6, B Wuyam6.   

Abstract

BACKGROUND: Specific alterations in skeletal muscle related to genetic defects may be present in adults with cystic fibrosis (CF). Limb muscle dysfunction may contribute to physical impairment in CF. AIMS AND
OBJECTIVES: We hypothesized that adults with CF would have altered calf muscle metabolism during exercise.
METHODS: Fifteen adults with CF and fifteen healthy controls matched for age, gender and physical activity performed a maximal cycling test and an evaluation of calf muscle energetics by 31P magnetic resonance spectroscopy before, during and after plantar flexions to exhaustion.
RESULTS: Maximal cycling test revealed lower exercise capacities in CF (VO2peak 2.44±0.11 vs. 3.44±0.23L·Min-1, P=0.03). At rest, calf muscle phosphorus metabolites and pHi were similar in CF and controls (P>0.05). Maximal power output during plantar flexions was significantly lower in CF compared to controls (7.8±1.2 vs. 6.6±2.4W; P=0.013). At exhaustion, PCr concentration was similarly reduced in both groups (CF -33±7%, controls -34±6%, P=0.44), while PCr degradation at identical absolute workload was greater in CF patients (P=0.04). These differences disappeared when power output was normalized for differences in calf size (maximal power output: 0.10±0.02 vs. 0.10±0.03W/cm2; P=0.87). Pi/PCr ratio and pHi during exercise as well as PCr recovery after exercise were similar between groups.
CONCLUSION: Similar metabolic calf muscle responses during exercise and recovery were found in CF adults and controls. Overall, muscle anabolism rather than specific metabolic dysfunction may be critical regarding muscle function in CF.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  (31)P MR spectroscopy; Cystic fibrosis; Exercise tolerance; Muscle metabolism

Mesh:

Year:  2016        PMID: 27316662     DOI: 10.1016/j.jcf.2016.05.010

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  4 in total

1.  Rebuttal from Paula Rodriguez-Miguelez, Melissa L. Erickson, Kevin K. McCully and Ryan A. Harris.

Authors:  Paula Rodriguez-Miguelez; Melissa L Erickson; Kevin K McCully; Ryan A Harris
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

2.  CrossTalk opposing view: Skeletal muscle oxidative capacity is not altered in cystic fibrosis patients.

Authors:  H J Erik Hulzebos; Jeroen A L Jeneson; Cornelis K van der Ent; Tim Takken
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

3.  Rebuttal from Erik H. J. Hulzebos, Jeroen A. L. Jeneson, Cornelis K. van der Ent, Maarten S. Werkman and Tim Takken.

Authors:  H J Erik Hulzebos; Jeroen A L Jeneson; Cornelis K van der Ent; Maarten S Werkman; Tim Takken
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

4.  Size-adjusted muscle power and muscle metabolism in patients with cystic fibrosis are equal to healthy controls - a case control study.

Authors:  Katharina Ruf; Meinrad Beer; Herbert Köstler; Andreas Max Weng; Henning Neubauer; Alexander Klein; Kathleen Platek; Kristina Roth; Ralph Beneke; Helge Hebestreit
Journal:  BMC Pulm Med       Date:  2019-12-30       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.